Antiplatelet drugs are pharmaceutical drugs that inhibit platelet activation and reduce coagulation. They are commonly used to treat and prevent heart attacks, strokes, and clots in arteries. Antiplatelet drugs work by blocking the effects of substances like thromboxane A2 and platelet aggregation stimulating factor (PSF) that stimulate platelets to aggregate. Common antiplatelet drugs include...
The antiplatelet drugs market is estimated to be valued at US$ 2321.37 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:
Antiplatelet drugs are medicines that are used to prevent or reduce the clumping or aggregation of platelets in the blood. These drugs help...